Aurobindo Pharma Limited
NSE:AUROPHARMA.NS
1528.1 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||||||||
| Net Income
| 31,729.7 | 26,125 | 33,727.4 | 73,435.9 | 37,430.4 | 30,913.5 | 32,411.8 | 30,608.4 | 27,224.6 | 21,678.5 | 15,325.2 | 3,741.1 | 1,082.3 | 5,634.5 | 7,522.5 | 726.2 | 2,917.4 | 2,064.2 | 985.6 | 182.9 | 1,525.4 |
| Depreciation & Amortization
| 15,216.6 | 12,445.8 | 11,265.2 | 10,553.9 | 9,667.1 | 6,679.5 | 5,579.7 | 4,276.3 | 3,926.1 | 3,326.1 | 3,125.3 | 2,487.4 | 2,005.3 | 1,715 | 1,493.4 | 1,276 | 1,003.8 | 997.2 | 721.3 | 646.7 | 589.8 |
| Deferred Income Tax
| 0 | -3,396.4 | 0 | -12,016.4 | 0 | 0 | -8,000.3 | -8,507.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 89.1 | -57.5 | 0 | 86.2 | 0 | 0 | 0.1 | -1.4 | -5.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -16,750.7 | -10,949.8 | 15,578 | -10,667.8 | 2,768.7 | -15,102.6 | -10,689.8 | 6,110 | -7,383.3 | -8,417.3 | -10,590.9 | -4,215.6 | -1,283.3 | -4,706.3 | -2,608.9 | -3,339.6 | -1,271.7 | -2,667.4 | -1,732.1 | -48.4 | -2,118.6 |
| Accounts Receivables
| -2,641.9 | -4,321.1 | -4,108.4 | 7,440.4 | -6,561.2 | -202.4 | -656.6 | 17,728.6 | -11,103.5 | -2,281.4 | -11,016.1 | -3,672.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -13,036.8 | -9,267 | 14,975.2 | -15,935.8 | -5,269.8 | -8,860.4 | -14,126.7 | -2,744 | -4,768 | -5,730.4 | -4,379 | -3,780.3 | -902.9 | -3,750.4 | -2,228.9 | -682.5 | -1,406.3 | -1,832.2 | -926.4 | -560.7 | -653.8 |
| Accounts Payables
| 5,828.4 | 7,076.5 | 1,106.5 | 1,264.2 | 2,958.7 | -3,743.4 | 3,966.9 | -1,572.7 | 4,451.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -6,900.4 | -4,438.2 | 3,604.7 | -3,436.6 | 11,641 | -2,296.4 | 3,436.9 | 8,854 | -2,615.3 | -2,686.9 | -6,211.9 | -435.3 | -380.4 | -955.9 | -380 | -2,657.1 | 134.6 | -835.2 | -805.7 | 512.3 | -1,464.8 |
| Other Non Cash Items
| 34,735 | -299.6 | -10,405.8 | -28,102.6 | -6,053.4 | -6,270.1 | 246.7 | 299.9 | -6,171.7 | -4,219.2 | -1,396.8 | 735.8 | 1,457.8 | 790.5 | -2,119.6 | 2,697.7 | -1,062.3 | -207.5 | -65.3 | 439.4 | 202.3 |
| Operating Cash Flow
| 24,647.1 | 23,867.5 | 50,164.8 | 33,289.2 | 43,812.8 | 16,220.3 | 19,548.2 | 32,785.8 | 17,595.7 | 12,368.1 | 6,462.8 | 2,748.7 | 3,262.1 | 3,433.7 | 4,287.4 | 1,360.3 | 1,587.2 | 186.5 | -90.5 | 1,220.6 | 198.9 |
| Investing Activities: | |||||||||||||||||||||
| Investments In Property Plant And Equipment
| -35,615 | -27,204 | -27,046.4 | -18,738.1 | -14,310.9 | -16,054.1 | -15,299.2 | -16,941.5 | -15,681.5 | -7,682.9 | -3,904.8 | -2,732.6 | -5,713.2 | -7,159.2 | -4,198.9 | -4,830 | -2,462.9 | -3,318.7 | -2,037.2 | -3,286.3 | -2,004.7 |
| Acquisitions Net
| 602.8 | -915.9 | -6,247.5 | 25,920.7 | -1,687.5 | -13,199 | -7,336.5 | -1,179 | 1,379.6 | -6,860.3 | -242.2 | 0 | 0 | 838.5 | 0 | 0 | 0 | -284.7 | -377.2 | 303.2 | 43.4 |
| Purchases Of Investments
| -257 | -20,141 | -8,249.5 | -1,597.8 | -1,876.8 | -463.1 | -677.6 | -1,179 | -571.1 | 0 | 0 | 0 | 0 | 0 | -31.1 | 0 | 0 | -2,051.1 | -0.4 | -312.5 | -1,281.9 |
| Sales Maturities Of Investments
| 1,791.5 | 23,514.7 | 4,616.5 | -3,685.5 | 1,876.8 | 463.1 | 0 | 0 | 293.9 | 0 | 0 | 0 | 0 | 263.6 | 0 | 476.4 | 1,276.4 | 0 | 143.2 | 312.5 | 1,291.7 |
| Other Investing Activites
| -11,890.2 | -15,031.3 | 4,811.3 | 4,087.6 | 322 | 484.8 | 3,066.2 | 250.1 | 501.3 | 458.1 | -4,040.4 | 269.2 | 82 | 112.4 | 239.8 | 290.8 | 436.4 | 521.3 | -40.3 | 259.2 | 14.4 |
| Investing Cash Flow
| -45,367.9 | -39,777.5 | -32,115.6 | 5,986.9 | -15,676.4 | -28,768.3 | -19,569.5 | -17,870.4 | -13,800.6 | -14,085.1 | -8,187.4 | -2,463.4 | -5,631.2 | -5,944.7 | -3,990.2 | -4,062.8 | -750.1 | -5,133.2 | -2,311.9 | -2,723.9 | -1,937.1 |
| Financing Activities: | |||||||||||||||||||||
| Debt Repayment
| -14,613.1 | -56.5 | -26,366.6 | -11,370.1 | -2,169.8 | -3,938.3 | -9,370.9 | -9,132.6 | -5,875.2 | -1,352.2 | -510.8 | -5,231 | -2,905 | -995.7 | -1,350.9 | -1,969.3 | -1,438.6 | -2,463.2 | -750.7 | -170.9 | -1,555.6 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 1.9 | 0.6 | 2.3 | 66.6 | 72 | 67.6 | 34.5 | 8.2 | 0 | 10.8 | 54.4 | 0 | 15.3 | 28.4 | 587.9 | 0 | 1,088.4 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | -15,419.9 | 24,727.1 | 20,651.4 | -8,714.8 | 7,220.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,202.5 |
| Dividends Paid
| -2,636.4 | -4,395.3 | -2,637 | -2,343.1 | -1,884 | -1,460.2 | -2,194 | -1,139.5 | -1,341.9 | -1,527 | -595.5 | -674.3 | -338.2 | -474.7 | -288.5 | -393.2 | -157.1 | -92.3 | -30.3 | -129.8 | -90.5 |
| Other Financing Activities
| -3,354.1 | 22,595.9 | -689.1 | 65.1 | -127.9 | -138.6 | -447.3 | -232.3 | -273.6 | 2,216.7 | 2,248.2 | 6,978 | 4,431.7 | 5,529.4 | 709 | 4,012.4 | -595.1 | 9,365.9 | 3,921.3 | 1,748.8 | 328.5 |
| Financing Cash Flow
| 10,510.7 | 18,144.1 | -29,692.7 | -13,648.1 | -19,471.8 | 19,190.6 | 8,641.5 | -19,152.6 | -198.3 | 932.1 | 1,176.4 | 1,080.9 | 1,188.5 | 4,069.8 | -876 | 1,649.9 | -2,175.5 | 6,838.8 | 3,728.2 | 1,448.1 | 1,973.3 |
| Other Information: | |||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 141.7 | -0.6 | 2 | -21.2 | 47.8 | 13.8 | -1.7 | -1.5 | -3 | 15.1 | -1.2 | 4.7 | -0.1 | -101.4 | 16.6 | -334.6 | -9.7 | 7.6 | 43.4 | 25 | -108 |
| Net Change In Cash
| 18,795.2 | 2,297.6 | -11,674 | 25,830.9 | 8,712.4 | 6,656.4 | 8,922.1 | -4,238.7 | 3,634.5 | 3,025.4 | -547.1 | 1,370.9 | -1,180.7 | 1,417.9 | -554.6 | -1,387.2 | -1,348.1 | 1,899.8 | 1,369.2 | -30.2 | 127.1 |
| Cash At End Of Period
| 62,783 | 43,922.7 | 41,625.1 | 53,299.1 | 27,468.2 | 18,755.8 | 12,118.4 | 3,196.3 | 8,245.5 | 4,505.6 | 1,480.2 | 2,027.3 | 656.4 | 1,865.1 | 471.9 | 969.6 | 2,399.4 | 3,861.5 | 1,963 | 592.4 | 624.6 |